MIMIX Trademark
Trademark Overview
On Monday, May 6, 2024, a trademark application was filed for MIMIX with the United States Patent and Trademark Office. The USPTO has given the MIMIX trademark a serial number of 98536299. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, November 25, 2024. This trademark is owned by Vaxess Technologies, Inc.. The MIMIX trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of a wide range of pharmaceuticals, and applicators therefor; drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of pharmaceuticals, namely, vaccines, anti-viral therapies, immunotherapies, hormones for medical purposes, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases, and applicators therefor; patches, polymers, and resorbable microneedles that provide transdermal delivery of vitamins and nutritional supplements, and applicators therefor
General Information
| Serial Number | 98536299 |
| Word Mark | MIMIX |
| Filing Date | Monday, May 6, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, November 25, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of a wide range of pharmaceuticals, and applicators therefor; drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of pharmaceuticals, namely, vaccines, anti-viral therapies, immunotherapies, hormones for medical purposes, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases, and applicators therefor; patches, polymers, and resorbable microneedles that provide transdermal delivery of vitamins and nutritional supplements, and applicators therefor |
| Pseudo Mark | MI MIX; MIMICS |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 6, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vaxess Technologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
Trademark Events
| Event Date | Event Description |
| Monday, May 6, 2024 | NEW APPLICATION ENTERED |
| Monday, May 6, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 20, 2024 | ASSIGNED TO EXAMINER |
| Monday, November 25, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, November 25, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, November 25, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
